65 related articles for article (PubMed ID: 12730502)
1. Cytokine balance in kidney tissue from lupus nephritis patients.
Uhm WS; Na K; Song GW; Jung SS; Lee T; Park MH; Yoo DH
Rheumatology (Oxford); 2003 Aug; 42(8):935-8. PubMed ID: 12730502
[TBL] [Abstract][Full Text] [Related]
2. Theoretical Studies of DNA Microarray Present Potential Molecular and Cellular Interconnectivity of Signaling Pathways in Immune System Dysregulation.
Garcia JPT; Tayo LL
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674328
[TBL] [Abstract][Full Text] [Related]
3. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis.
Pandey R; Bakay M; Hakonarson H
Front Immunol; 2023; 14():1271102. PubMed ID: 38022642
[TBL] [Abstract][Full Text] [Related]
4. Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional study.
Alduraibi FK; Sullivan KA; Chatham WW; Hsu HC; Mountz JD
Clin Immunol; 2023 Feb; 247():109239. PubMed ID: 36682593
[TBL] [Abstract][Full Text] [Related]
5. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
Knapp J; Braunstein M; Berg SIT; Shirriff C
Arthritis Res Ther; 2022 Dec; 24(1):267. PubMed ID: 36510250
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of helper T cell type 1, helper T cell type 2 and associated cytokines in patients with systemic lupus erythematosus: A meta-analysis.
Xiang S; Zhang J; Zhang M; Qian S; Wang R; Wang Y; Xiang Y; Ding X
Front Pharmacol; 2022; 13():988512. PubMed ID: 36249802
[No Abstract] [Full Text] [Related]
7. Anti-C1q autoantibodies from systemic lupus erythematosus patients enhance CD40-CD154-mediated inflammation in peripheral blood mononuclear cells
Rabatscher PA; Trendelenburg M
Clin Transl Immunology; 2022; 11(8):e1408. PubMed ID: 35928801
[TBL] [Abstract][Full Text] [Related]
8. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
9. Integrated urine proteomics and renal single-cell genomics identify an IFN-γ response gradient in lupus nephritis.
Fava A; Buyon J; Mohan C; Zhang T; Belmont HM; Izmirly P; Clancy R; Trujillo JM; Fine D; Zhang Y; Magder L; Rao DA; Arazi A; Berthier CC; Davidson A; Diamond B; Hacohen N; Wofsy D; Apruzzese W; ; Raychaudhuri S; Petri M
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32396533
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-25 and its association to Th2 cytokines in systemic lupus erythematosus with lupus nephritis.
Selvaraja M; Abdullah M; Arip M; Chin VK; Shah A; Amin Nordin S
PLoS One; 2019; 14(11):e0224707. PubMed ID: 31697750
[TBL] [Abstract][Full Text] [Related]
11. Novel and Stable Dual-Color IL-6 and IL-10 Reporters Derived from RAW 264.7 for Anti-Inflammation Screening of Natural Products.
Saiki P; Kawano Y; Nakajima Y; Van Griensven LJLD; Miyazaki K
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540402
[TBL] [Abstract][Full Text] [Related]
12. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus.
Rahman S; Sagar D; Hanna RN; Lightfoot YL; Mistry P; Smith CK; Manna Z; Hasni S; Siegel RM; Sanjuan MA; Kolbeck R; Kaplan MJ; Casey KA
Ann Rheum Dis; 2019 Jul; 78(7):957-966. PubMed ID: 31040119
[TBL] [Abstract][Full Text] [Related]
13. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
Katsuyama T; Tsokos GC; Moulton VR
Front Immunol; 2018; 9():1088. PubMed ID: 29868033
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effect of
Wang Q; Sun P; Wang R; Zhao X
Pharmacogn Mag; 2017; 13(49):129-135. PubMed ID: 28216896
[TBL] [Abstract][Full Text] [Related]
15. Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han Population.
Sigdel KR; Duan L; Wang Y; Hu W; Wang N; Sun Q; Liu Q; Liu X; Hou X; Cheng A; Shi G; Zhang Y
Mediators Inflamm; 2016; 2016():4927530. PubMed ID: 27738386
[TBL] [Abstract][Full Text] [Related]
16. JAK3-STAT pathway blocking benefits in experimental lupus nephritis.
Ripoll È; de Ramon L; Draibe Bordignon J; Merino A; Bolaños N; Goma M; Cruzado JM; Grinyó JM; Torras J
Arthritis Res Ther; 2016 Jun; 18(1):134. PubMed ID: 27278657
[TBL] [Abstract][Full Text] [Related]
17. Glomerular cytokine expression in murine lupus nephritis.
Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis: the evolving role of novel therapeutics.
Rovin BH; Parikh SV
Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
[TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.
Peng H; Wang W; Zhou M; Li R; Pan HF; Ye DQ
Clin Rheumatol; 2013 Sep; 32(9):1255-66. PubMed ID: 23708831
[TBL] [Abstract][Full Text] [Related]
20. Novel treatments for systemic lupus erythematosus.
Xiong W; Lahita RG
Ther Adv Musculoskelet Dis; 2011 Oct; 3(5):255-66. PubMed ID: 22870484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
